Concepedia

Publication | Open Access

Phase II Study of Daily Sunitinib in FDG-PET–Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation

DOIFull Paper Access

417

Citations

17

References

2010

Year

Laurie L. Carr, David A. Mankoff, Bernardo Goulart, Keith D. Eaton, Peter Capell, Elizabeth Kell, Julie E. Bauman, Renato Martins
Clinical Cancer Research

Abstract

Continuous administration of sunitinib was effective in patients with iodine-refractory WDTC and MTC. Further study is warranted.

References

YearCitations

Page 1